Dr. Wendy Weber to serve as director of the National Center for Complementary and Integrative Health

Today, National Institutes of Health Director Jay Bhattacharya, M. D, Ph. D, announced that Wendy Weber, N. D, Ph. D, has been selected to serve as director of NIH’s National Center for Complementary and Integrative Health. The institutional report frames the development in practical terms and ties it to the broader mission or observing effort.

The significance lies in biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. Today, National Institutes of Health (NIH) Director Jay Bhattacharya, M. D, Ph. D, announced that Wendy Weber, N. D, Ph. She began her new role on August 23, 2026.

Weber’s history of leadership in whole-person health, pain management research, and deep connection to NIH make her a natural fit to lead the center into a new chapter of rigorous. Weber will manage the administration of the center’s approximately $170 million budget.

NCCIH supports research that aims to determine the fundamental science, usefulness, and safety of complementary and integrative health approaches and their roles in improving. During her more than 15 years with NIH, Dr.

She also provided scientific leadership to the multi-Institute NIH Pragmatic Trials Collaboratory and the NIH-VA-DoD Pain Management Collaboratory. Prior to joining NIH as a program director in 2009, Dr.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

She was the first naturopathic physician to receive an NIH career development (K) award, which supported her clinical trial of St. David Shurtleff who has served as Acting Director of NCCIH since October 2025,” said Dr.

Because the account originates with NIH News Releases, it functions best as a primary institutional report that is close to the data and operations, not as independent scientific validation. Institutional communications are produced by organizations with legitimate interests in presenting their work in a favorable light, which does not make them unreliable but does make them partial. Details that complicate the narrative, including instrument limitations, unexpected failures and results below projections, tend to be minimized relative to progress messages. Technical documentation and peer-reviewed publications, where they exist, provide the complementary layer that institutional releases cannot substitute.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source